Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

The challenge of targeting metastasis.

Fidler IJ, Kripke ML.

Cancer Metastasis Rev. 2015 Dec;34(4):635-41. doi: 10.1007/s10555-015-9586-9. Review.

2.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC Jr, Bennett JM, Benz EJ Jr, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ Jr, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA.

Mayo Clin Proc. 2015 Aug;90(8):996-1000. doi: 10.1016/j.mayocp.2015.06.001. Epub 2015 Jul 23. No abstract available.

3.

Breast cancer and environmental research.

Brody JG, Kripke ML, Kavanaugh-Lynch MH, Rizzo J, Forman MR.

Science. 2014 May 9;344(6184):577. doi: 10.1126/science.344.6184.577-a. No abstract available.

PMID:
24812379
4.

Reflections on the field of photoimmunology.

Kripke ML.

J Invest Dermatol. 2013 Jan;133(1):27-30. doi: 10.1038/jid.2012.234. Epub 2012 Aug 2. Review.

5.

Reducing death from cancer: what will it take?

Kripke ML.

Tumour Biol. 2012 Oct;33(5):1275-8. doi: 10.1007/s13277-012-0425-0. Epub 2012 Jun 5.

PMID:
22664949
6.
7.

p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer.

Benjamin CL, Ullrich SE, Kripke ML, Ananthaswamy HN.

Photochem Photobiol. 2008 Jan-Feb;84(1):55-62. doi: 10.1111/j.1751-1097.2007.00213.x. Review.

PMID:
18173701
8.

Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.

Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q.

Clin Cancer Res. 2007 Nov 1;13(21):6532-9.

9.

Mortality risk from squamous cell skin cancer.

Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM.

J Clin Oncol. 2005 Feb 1;23(4):759-65.

PMID:
15681519
10.

Viability of the antigen determines whether DNA or urocanic acid act as initiator molecules for UV-induced suppression of delayed-type hypersensitivity.

Kim TH, Moodycliffe AM, Yarosh DB, Norval M, Kripke ML, Ullrich SE.

Photochem Photobiol. 2003 Sep;78(3):228-34.

PMID:
14556308
11.

Advantages of using hairless mice versus haired mice to test sunscreen efficacy against photoimmune suppressions.

Kim TH, Ananthaswamy HN, Kripke ML, Ullrich SE.

Photochem Photobiol. 2003 Jul;78(1):37-42.

PMID:
12929746
12.

The ABCs of sunscreen protection factors.

Kripke ML.

J Invest Dermatol. 2003 Jul;121(1):VII-VIII. Review. No abstract available.

13.

Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population.

Fidler IJ, Kripke ML.

Nat Genet. 2003 May;34(1):23; author reply 25. No abstract available.

PMID:
12721548
14.

Health effects from stratospheric ozone depletion and interactions with climate change.

de Gruijl FR, Longstreth J, Norval M, Cullen AP, Slaper H, Kripke ML, Takizawa Y, van der Leun JC.

Photochem Photobiol Sci. 2003 Jan;2(1):16-28. Review. Erratum in: Photochem Photobiol Sci. 2003 Mar;2(3):354.

PMID:
12659536
15.

p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.

Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN.

Clin Cancer Res. 2003 Jan;9(1):228-34.

16.
17.

Photoprotection against UV-damage. Conclusions and perspectives.

Fourtanier A, Kripke M.

Exp Dermatol. 2002;11 Suppl 1:48. No abstract available.

PMID:
12444961
18.

Inhibition of UV-induced p53 mutations and skin cancers by sunscreens: implication for skin cancer prevention.

Ananthaswamy HN, Ullrich SE, Kripke ML.

Exp Dermatol. 2002;11 Suppl 1:40-3.

PMID:
12444959
19.

Mechanisms underlying UV-induced immune suppression: implications for sunscreen design.

Ullrich SE, Kripke ML, Ananthaswamy HN.

Exp Dermatol. 2002;11 Suppl 1:13-6.

PMID:
12444953
20.

New measures of photoprotection.

Kripke M.

Exp Dermatol. 2002;11 Suppl 1:7-8. No abstract available.

PMID:
12444951
21.

Mechanisms underlying the suppression of established immune responses by ultraviolet radiation.

Nghiem DX, Kazimi N, Mitchell DL, Vink AA, Ananthaswamy HN, Kripke ML, Ullrich SE.

J Invest Dermatol. 2002 Sep;119(3):600-8.

22.

Ultraviolet a radiation suppresses an established immune response: implications for sunscreen design.

Nghiem DX, Kazimi N, Clydesdale G, Ananthaswamy HN, Kripke ML, Ullrich SE.

J Invest Dermatol. 2001 Nov;117(5):1193-9.

23.

UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53.

Jiang W, Ananthaswamy HN, Muller HK, Ouhtit A, Bolshakov S, Ullrich SE, El-Naggar AK, Kripke ML.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9790-5. Epub 2001 Jul 31.

24.

The effect of UV irradiation on infection of mice with Borrelia burgdorferi.

Brown EL, Ullrich SE, Pride M, Kripke ML.

Photochem Photobiol. 2001 May;73(5):537-44.

PMID:
11367577
25.

Impact of Bcl-2 and Ha-ras on keratinocytes in organotypic culture.

Delehedde M, Cho SH, Hamm R, Brisbay S, Ananthaswamy HN, Kripke M, McDonnell TJ.

J Invest Dermatol. 2001 Mar;116(3):366-73.

26.
27.

The Monodelphis melanoma model: initial report on large ultraviolet A exposures of suckling young.

Robinson ES, Hill RH Jr, Kripke ML, Setlow RB.

Photochem Photobiol. 2000 Jun;71(6):743-6.

PMID:
10857371
28.

CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes.

Moodycliffe AM, Shreedhar V, Ullrich SE, Walterscheid J, Bucana C, Kripke ML, Flores-Romo L.

J Exp Med. 2000 Jun 5;191(11):2011-20.

29.

Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha.

Wolf P, Maier H, Müllegger RR, Chadwick CA, Hofmann-Wellenhof R, Soyer HP, Hofer A, Smolle J, Horn M, Cerroni L, Yarosh D, Klein J, Bucana C, Dunner K Jr, Potten CS, Hönigsmann H, Kerl H, Kripke ML.

J Invest Dermatol. 2000 Jan;114(1):149-56.

30.

Dendritic cells require T cells for functional maturation in vivo.

Shreedhar V, Moodycliffe AM, Ullrich SE, Bucana C, Kripke ML, Flores-Romo L.

Immunity. 1999 Nov;11(5):625-36.

31.

Sunscreen effects on UV-induced immune suppression.

Ullrich SE, Kim TH, Ananthaswamy HN, Kripke ML.

J Investig Dermatol Symp Proc. 1999 Sep;4(1):65-9. Review.

32.

Fas ligand: a sensor for DNA damage critical in skin cancer etiology.

Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB.

Science. 1999 Aug 6;285(5429):898-900.

33.

p53 protects against skin cancer induction by UV-B radiation.

Jiang W, Ananthaswamy HN, Muller HK, Kripke ML.

Oncogene. 1999 Jul 22;18(29):4247-53.

34.

Direct comparison of DNA damage, isomerization of urocanic acid and edema in the mouse produced by three commonly used artificial UV light sources.

Yarosh DB, Kibitel J, Ullrich SE, Kim TH, Ananthaswamy HN, Krien P, Fourtanier A, Kripke ML.

Photochem Photobiol. 1999 May;69(5):571-4.

PMID:
10333763
35.

Inhibition of solar simulator-induced p53 mutations and protection against skin cancer development in mice by sunscreens.

Ananthaswamy HN, Ullrich SE, Mascotto RE, Fourtanier A, Loughlin SM, Khaskina P, Bucana CD, Kripke ML.

J Invest Dermatol. 1999 May;112(5):763-8.

36.

A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation.

Hill LL, Shreedhar VK, Kripke ML, Owen-Schaub LB.

J Exp Med. 1999 Apr 19;189(8):1285-94.

37.

Health risks.

Longstreth J, de Gruijl FR, Kripke ML, Abseck S, Arnold F, Slaper HI, Velders G, Takizawa Y, van der Leun JC.

J Photochem Photobiol B. 1998 Oct;46(1-3):20-39. Review.

PMID:
9894351
38.

Suppression of delayed and contact hypersensitivity responses in mice have different UV dose responses.

Kim TH, Ullrich SE, Ananthaswamy HN, Zimmerman S, Kripke ML.

Photochem Photobiol. 1998 Nov;68(5):738-44.

PMID:
9825703
39.

Molecular regulation of UVB-induced cutaneous angiogenesis.

Bielenberg DR, Bucana CD, Sanchez R, Donawho CK, Kripke ML, Fidler IJ.

J Invest Dermatol. 1998 Nov;111(5):864-72.

40.

Cellular target of UVB-induced DNA damage resulting in local suppression of contact hypersensitivity.

Vink AA, Shreedhar V, Roza L, Krutmann J, Kripke ML.

J Photochem Photobiol B. 1998 Jul 10;44(2):107-11. Review.

PMID:
9757591
41.

HindIII liposomes suppress delayed-type hypersensitivity responses in vivo and induce epidermal IL-10 in vitro.

Nishigori C, Yarosh D, O'Connor A, Shreedhar VK, Ullrich SE, Cox P, Kripke ML.

J Immunol. 1998 Sep 15;161(6):2684-91.

42.

Inhibition of UV-induced p53 mutations by sunscreens: implications for skin cancer prevention.

Ananthaswamy HN, Loughlin SM, Ullrich SE, Kripke ML.

J Investig Dermatol Symp Proc. 1998 Aug;3(1):52-6. Review.

43.

Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes.

Shreedhar VK, Pride MW, Sun Y, Kripke ML, Strickland FM.

J Immunol. 1998 Aug 1;161(3):1327-35.

44.

Dose-responses for UV-induced suppression of various immune responses.

Kim T, Ullrich SE, Kripke ML.

Eur J Dermatol. 1998 Apr-May;8(3):195. No abstract available.

PMID:
9649672
45.

Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice.

Pride MW, Brown EL, Stephens LC, Killion JJ, Norris SJ, Kripke ML.

J Leukoc Biol. 1998 May;63(5):542-9.

PMID:
9581797
46.

p53 Mutations in hairless SKH-hr1 mouse skin tumors induced by a solar simulator.

Ananthaswamy HN, Fourtanier A, Evans RL, Tison S, Medaisko C, Ullrich SE, Kripke ML.

Photochem Photobiol. 1998 Feb;67(2):227-32.

PMID:
9487800
47.

Immunologic protection afforded by sunscreens beyond designated sun protection factors?

Wolf P, Kripke ML.

J Invest Dermatol. 1998 Feb;110(2):184. No abstract available.

48.

Immune response associated with nonmelanoma skin cancer.

Strickland FM, Kripke ML.

Clin Plast Surg. 1997 Oct;24(4):637-47. Review.

PMID:
9342507
49.

The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers.

Vink AA, Moodycliffe AM, Shreedhar V, Ullrich SE, Roza L, Yarosh DB, Kripke ML.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5255-60.

50.

Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens.

Ananthaswamy HN, Loughlin SM, Cox P, Evans RL, Ullrich SE, Kripke ML.

Nat Med. 1997 May;3(5):510-4.

PMID:
9142118

Supplemental Content

Loading ...
Support Center